Search

everythinglearnresearchcommunity

for

Search:↓

The conversation humorously suggests that the hair loss industry, referred to as "Big Bald," deliberately delays a cure to profit from ongoing treatments like minoxidil, finasteride, and dutasteride. Participants debate whether a cure would be more profitable than current treatments, with some suggesting that the industry prefers continuous treatments for sustained profit.

The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

The user experienced significant hair regrowth using finasteride and minoxidil but developed erectile dysfunction. They are considering stopping finasteride and relying on minoxidil alone to see if the side effects improve.

The user is concerned about having a straight, low hairline after a hair transplant and is unable to take finasteride due to high estrogen and prolactin levels. They have used minoxidil with limited success and are considering further transplants to lower the hairline, while others suggest the risks of using up donor hair too quickly.

The conversation discusses hair loss, genetics, and treatments like Dutasteride. It highlights the influence of genetics on hair loss, noting that indigenous people are less prone to it.

Finasteride changed the user's hair texture from wavy to curly, reverting after stopping. Minoxidil was more effective for temple hair regrowth than finasteride.

The user is experiencing significant hair regrowth after using finasteride and minoxidil for about two months, with no major side effects reported. The conversation highlights the importance of consistency and patience in hair treatment, as full results can take several years.

Individuals discussing hair loss treatments, including finasteride and minoxidil, express mixed results and concerns about effectiveness after two years. Some consider switching to dutasteride or exploring other options like hair transplants.

A new drug, PP405, is being discussed as a potential cure for baldness, with hopes it could be more effective than Minoxidil and Finasteride. Users are skeptical about its effectiveness and the need for lifelong use.

The user is experiencing rapid hair loss despite using dutasteride, finasteride, and minoxidil, and is concerned about high estradiol and testosterone levels. They are advised to consult an endocrinologist for potential hormonal imbalances.

The user is experiencing excessive hair thinning and is unsure of the cause. They are seeking opinions on treatments like Minoxidil, finasteride, and RU58841.

A user shared their positive experience with hair regrowth after three months using topical minoxidil twice daily, 1mg finasteride every morning, and microneedling every 10 days. They reported no side effects and encouraged others to consider similar treatments.

Having hair improves social interactions and treatment by others, with hair transplants and finasteride enhancing confidence and attractiveness. People often receive more positive attention after addressing hair loss.

The user transitioned from finasteride to RU58841 and oral minoxidil to maintain hair gains while avoiding systemic DHT suppression. They have not experienced increased shedding or side effects since stopping finasteride and hope RU58841 will preserve their hair.

The user switched from finasteride to dutasteride and experienced hair thinning, which is expected during the transition. They are using ketoconazole shampoo, considering dermarolling, and adding topical minoxidil to their routine.

The user has been using oral finasteride, oral minoxidil, topical minoxidil, and microneedling to address hair loss but continues to experience recession after 8 months. Suggestions include being patient as treatments can take 12-18 months to show effects, considering a switch to dutasteride, and consulting a dermatologist for potential underlying scalp conditions.

The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil due to lack of results. They are hopeful about dutasteride but are prepared to stop all medication if it doesn't work, as they have aggressive hair loss genetics.

An 18-year-old is using a high-dose treatment for hair loss, including 2.5 mg dutasteride, topical minoxidil, and injectable GHK-Cu, despite minimal hair loss. Many users suggest reducing the dutasteride dose due to potential side effects and recommend starting with finasteride instead.

The user experienced significant hair loss after three years on finasteride, possibly due to inconsistent use, stress, or a cyclical shed. Suggestions included using reminders for consistent medication intake, considering dutasteride, and addressing stress factors.

A user has been using 1mg oral finasteride and 5% topical minoxidil for six months, with some derma stamping, but feels hair growth has stagnated and is considering PRP or a hair transplant. Others advise continuing the current regimen, noting that maintaining existing hair is an achievement, and suggest ignoring negative comments from friends.

The user experienced significant hair regrowth after nearly 7 months using 1mg finasteride daily and 5% minoxidil twice daily. They are considering adding microneedling to enhance results and are pleased with the progress so far.

The user is experiencing hair loss and has been using topical Minoxidil 5%, Keto 2% shampoo, and Tretinoin 0.025% for six months, with plans to start topical Finasteride 0.1% soon. They are advised to focus on DHT blockers like Finasteride and consider additional tests and supplements to address potential deficiencies and scalp health.

Hair cloning for hair loss is unlikely to be available or affordable in the next 10 years. Current treatments like Minoxidil, finasteride, and RU58841 are still the main options, with skepticism about new advancements.

Finasteride can cause side effects like erectile dysfunction and decreased libido, possibly due to increased estradiol from testosterone aromatization, especially in those with higher body fat. Side effects vary widely and may also be influenced by genetic factors or neurosteroid inhibition.

People are excited about a new hair loss treatment, PP405, and some suggest using Twitter to increase its visibility. Current treatments mentioned include finasteride, minoxidil, and dutasteride, but skepticism remains about the effectiveness of new treatments.

The conversation is about a user planning to start minoxidil treatment and considering increasing zinc intake to improve testosterone and libido. They are concerned about potential hair loss due to increased testosterone and are advised to consider magnesium supplementation and the effects of DHT if not on finasteride or dutasteride.

The user received 1600 hair grafts but is dissatisfied and plans a second transplant for better coverage. They use minoxidil and finasteride and are considering adding dutasteride.

The user has been using 2.5 mg oral minoxidil and 0.5 mg dutasteride after 14 months on finasteride with no significant regrowth observed. They are considering increasing the dutasteride dosage and adding topical minoxidil with tretinoin to potentially improve hair growth.

Finasteride may help prevent hair loss for those concerned about creatine, despite no proven link between creatine and hair loss. Personal experiences with creatine and hair shedding vary.

Cosmo Pharma plans to release Breezula, a hair loss treatment, with expected FDA approval in 2027, but concerns arise over its high potential cost of $225/month. Users express skepticism about its effectiveness compared to cheaper alternatives like finasteride and minoxidil.